[Federal Register Volume 78, Number 202 (Friday, October 18, 2013)]
[Notices]
[Page 62350]
[FR Doc No: 2013-24482]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 14539-000; Project No. 14540-000]

 Lock+ Hydro Friends Fund III, LLC; Western Minnesota Municipal
Power Agency; Notice Announcing Preliminary Permit Drawing

    The Commission has received two preliminary permit applications
deemed filed on July 23, 2013 at 8:30 a.m.,\1\ for proposed projects to
be located at the U.S. Army Corps of Engineers' Melvin Price Locks and
Dam on the Mississippi River, near the city of Alton, in Madison
County, Illinois, and the city of West Alton, in St. Charles County,
Missouri. The applications were filed by Lock+ Hydro Friends Fund III,
LLC for Project No. 14539-000 and Western Minnesota Municipal Power
Agency for Project No. 14540-000.
---------------------------------------------------------------------------

    \1\ Under the Commission's Rules of Practice and Procedure, any
document received after regular business hours is considered filed
at 8:30 a.m. on the next regular business day. See 18 CFR
385.2001(a)(2) (2013).
---------------------------------------------------------------------------

    On October 21, 2013, at 10:00 a.m. (Eastern Time), the Secretary of
the Commission, or her designee, will conduct a random drawing to
determine the filing priority of the applicants identified in this
notice. The Commission will select between the two competing permit
applications as provided in section 4.37 of its regulations.\2\ The
priority established by this drawing will be used to determine which
applicant, between those with identical filing times, will be
considered to have the first-filed application.
---------------------------------------------------------------------------

    \2\ See id. 4.37.
---------------------------------------------------------------------------

    The drawing is open to the public and will be held in room 2C, the
Commission Meeting Room, located at 888 First Street NE., Washington,
DC 20426. The Secretary will issue a subsequent notice announcing the
results of the drawing.

    Dated: October 10, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-24482 Filed 10-17-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 216 (Thursday, November 7, 2019)]
[Notices]
[Pages 60100-60101]
[FR Doc No: 2019-24297]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2010-1066]

Recreational Boating Safety Projects, Programs, and Activities
Funded Under Provisions of the Fixing America's Surface Transportation
Act; Fiscal Year 2019

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard is publishing this notice to satisfy a
requirement of the Fixing America's Surface Transportation Act that
requires a detailed accounting of the projects, programs, and
activities funded under the national recreational boating safety
program provision of the Act be published annually in the Federal
Register. This notice specifies the funding amounts the Coast Guard has
committed, obligated, or expended during fiscal year 2019, as of
September 30, 2019.

FOR FURTHER INFORMATION CONTACT: For questions on this notice please
contact Mr. Jeffrey Decker, U.S. Coast Guard, Regulations Development
Manager,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Background and Purpose

    Since 1998, Congress has passed a series of laws providing funding
for projects, programs, and activities funded under the national
recreational boating safety program, which is administered by the U.S.
Coast Guard. For a detailed description of the legislative history,
please see the Recreational Boating Safety Projects, Programs, and
Activities Funded Under Provisions of the Fixing America's Surface
Transportation Act; Fiscal Year 2016 Notice published in the Federal
Register on April 12, 2017 (82 FR 17671).
    These funds are available to the Secretary from the Sport Fish
Restoration and Boating Trust Fund (Trust Fund) established under 26
U.S.C. 9504(a) for payment of Coast Guard expenses for personnel and
activities directly related to coordinating and carrying out the
national recreational boating safety program. Amounts made available
under this subsection remain available during the two succeeding fiscal
years. Any amount that is unexpended or unobligated at the end of the
3-year period during which it is available, shall be withdrawn by the
Secretary and allocated to the States in addition to any other amounts
available for allocation in the fiscal year in which they are withdrawn
or the following fiscal year.
    Use of these funds requires compliance with standard Federal
contracting rules with associated lead and processing times resulting
in a lag time between available funds and spending. The total amount of
funding transferred to the Coast Guard from the Trust Fund, and
committed, obligated, and/or expended during fiscal year 2019 for each
project is shown below.

Specific Accounting of Funds

    The total amount of funding transferred to the Coast Guard from the
Sport Fish Restoration and Boating Trust Fund and committed, obligated,
and/or expended during fiscal year 2019 for each project is shown in
the chart below.

------------------------------------------------------------------------
            Project                    Description             Cost
------------------------------------------------------------------------
46 U.S.C. 43 Compliance:         Provided for                 $2,456,799
 Inspection Program/Boat          continuance of the
 Testing Program.                 national recreational
                                  boat compliance
                                  inspection program,
                                  which began in January
                                  2001.
46 U.S.C. 43 Compliance: Staff   Provided for personnel          585,586
 Salaries and Travel.             to oversee
                                  manufacturer
                                  compliance with 46 USC
                                  43 requirements.
Administrative Overhead........  Office supplies........         109,101

Boating Accident Report          Provided for                    250,136
 Database (BARD) Web System.      maintaining the BARD
                                  Web System, which
                                  enables reporting
                                  authorities in the 50
                                  States, five U.S.
                                  Territories, and the
                                  District of Columbia
                                  to submit their
                                  accident reports
                                  electronically over a
                                  secure Internet
                                  connection.
Contract Personnel Support.....  Provided contract               672,553
                                  personnel to conduct
                                  boating safety-related
                                  research and analysis.
National Boating Safety          Provided for member              60,975
 Advisory Council.                travel and meeting
                                  costs for the National
                                  Boating Safety
                                  Advisory Council
                                  meetings.
Grant Management Training......  Provided to facilitate          109,531
                                  staff training on new
                                  grant management
                                  requirements.
Recreational Boating Safety      Provided for travel by          168,301
 Program Travel.                  employees of the
                                  Boating Safety
                                  Division to gather
                                  background and
                                  planning information
                                  for new recreational
                                  boating safety
                                  initiatives.
Reimbursable Salaries..........  Provided for 18               2,396,677
                                  personnel directly
                                  related to
                                  coordinating and
                                  carrying out the
                                  national recreational
                                  boating safety program.
Survey.........................  Provided for collecting         469,641
                                  data to support the
                                  National Recreational
                                  Boating Survey.
------------------------------------------------------------------------

    Of the $8.168 million made available to the Coast Guard in fiscal
year 2019, $1,971,866 has been committed, obligated, or expended and an
additional $5,307,440 of prior fiscal year funds have been committed,
obligated, or expended, as of September 30, 2019. The remainder of the
FY18 and FY19 funds made available to the Coast Guard (approximately
$6,231,389) may be retained for the allowable period for the National
Recreational Boating Survey, other projects, or transferred into the
pool of money available for allocation through the state grant program.

Authority

    This notice is issued pursuant to 5 U.S.C. 552 and 46 U.S.C.
13107(c)(4).

    Dated: October 31, 2019.
D.C. Barata,
Captain, U.S. Coast Guard, Director of Inspections & Compliance.
[FR Doc. 2019-24297 Filed 11-6-19; 8:45 am]
 BILLING CODE 9110-04-P


[Federal Register: September 16, 2009 (Volume 74, Number 178)]
[Rules and Regulations]
[Page 47435-47436]
[DOCID:fr16se09-2]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 524

[Docket No. FDA-2009-N-0665]

Ophthalmic and Topical Dosage Form New Animal Drugs; Diclofenac

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Final rule.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a supplemental new animal drug
application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The
supplemental NADA provides for a revised human food safety warning for
use of diclofenac sodium topical cream in horses.

DATES:  This rule is effective September 16, 2009.

FOR FURTHER INFORMATION CONTACT:  Melanie R. Berson, Center for
Veterinary Medicine (HFV-110), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855,<PHONE_NUMBER>, e-mail:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Boehringer Ingelheim Vetmedica, Inc., 2621
North Belt Highway, St. Joseph, MO 64506-2002, filed a supplement to
NADA 141-186 that provides for use of SURPASS (1% diclofenac sodium)
Topical Cream in horses for the control of pain and inflammation
associated with osteoarthritis. The supplemental NADA provides for a
revised human food safety warning on product labeling. The supplemental
NADA is approved as of August 25, 2009, and the regulations are amended
in 21 CFR 524.590 to reflect the approval.
    Approval of this supplemental NADA did not require review of
additional safety or effectiveness data or information. Therefore, a
freedom of information summary is not required.
    The agency has determined under 21 CFR 25.33(d)(1) that this action
is of a type that does not individually or cumulatively have a
significant effect on the human environment. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.

    This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Part 524

    Animal drugs.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 524 is
amended as follows:

PART 524--OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 524 continues to read as
follows:

    Authority:  21 U.S.C. 360b.

Sec.  524.590  [Amended]

0
2. In Sec.  524.590, remove the first sentence of paragraph (c)(3)
``Not for use in horses intended for food.'' and in its place add ``Do
not use in horses intended for human consumption.''.

    Dated: September 11, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E9-22292 Filed 9-15-09; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 81, Number 161 (Friday, August 19, 2016)]
[Notices]
[Pages 55463-55466]
[FR Doc No: 2016-19808]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0134]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Mammography Quality
Standards Act Requirements

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by
September 19, 2016.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX:<PHONE_NUMBER>, or emailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0309.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, Three White Flint North,10A-12M, 11601
Landsdown St., North Bethesda, MD 20852<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Mammography Quality Standards Act Requirements--21 CFR Part 900, OMB
Control Number 0910-0309--Extension

    The Mammography Quality Standards Act (Pub. L. 102-539) requires
the establishment of a Federal certification and inspection program for
mammography facilities; regulations and standards for accreditation and
certification bodies for mammography facilities; and standards for
mammography equipment, personnel, and practices, including quality
assurance. The intent of these regulations is to assure safe, reliable,
and accurate mammography on a nationwide level. Under the regulations,
as a first step in becoming certified, mammography facilities must
become accredited by an FDA-approved accreditation body (AB). This
requires undergoing a review of their clinical images and providing the
AB with information showing that they meet the equipment, personnel,
quality assurance, and quality control standards, and have a medical
reporting and recordkeeping program, a medical outcomes audit program,
and a consumer complaint mechanism. On the basis of this accreditation,
facilities are then certified by FDA or an FDA-approved State
certification agency and must prominently display their certificate.
These actions are taken to ensure safe, accurate, and reliable
mammography on a nationwide basis.
    The following sections of Title 21 of the Code of Federal
Regulations (CFR) are not included in the burden tables because they
are considered usual and customary practice and were part of the
standard of care prior to the implementation of the regulations.
Therefore, they resulted in no additional burden: 21 CFR 900.12(c)(1)
and (3) and 900.3(f)(1). Section 900.24(c) was also not included in the
burden tables because if a certifying State had its approval withdrawn,
FDA would take over certifying authority for the affected facilities.
Because FDA already has all the certifying State's electronic records,
there wouldn't be an additional reporting burden.
    We have rounded numbers in the ``Total Hours'' column in all three
burden tables. (Where the number was a portion of 1 hour, it has been
rounded to 1 hour. All other ``Total Hours'' have been rounded to the
nearest whole number.)

    We do not expect any respondents for Sec.  900.3(c) because all
four ABs are approved until April 2020.
    In the Federal Register of June 8, 2016 (81 FR 36924), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
    FDA estimates the burden of this collection of information as
follows:

                                                       Table 1--Estimated Annual Reporting Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Total
                                                                       Number of                    Average                     Total      operating and
         Activity/21 CFR Section/Form FDA No.            Number of     responses   Total annual    burden per   Total hours    capital      maintenance
                                                        respondents       per        responses      response        \1\       costs (in     costs  (in
                                                                      respondent                                               dollars)      dollars)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Notification of intent to become an AB--900.3(b)(1)..          0.33             1          0.33          1                1  ...........  ..............
Application for approval as an AB; full \2\--                  0.33             1          0.33        320              106       10,000  ..............
 900.3(b)(3).........................................
Application for approval as an AB; limited \3\--               5                1          5            30              150  ...........  ..............
 900.3(b)(3).........................................
AB renewal of approval--900.3(c).....................          0                1          0            15                1  ...........  ..............
AB application deficiencies--900.3(d)(2).............          0.1              1          0.1          30                3  ...........  ..............
AB resubmission of denied applications--900.3(d)(5)..          0.1              1          0.1          30                3  ...........  ..............
Letter of intent to relinquish accreditation                   0.1              1          0.1           1                1  ...........  ..............
 authority--900.3(e).................................
Summary report describing all facility assessments--         330                1        330             7            2,310  ...........          77,600
 900.4(f)............................................
AB reporting to FDA; facility \4\--900.4(h)..........      8,654                1      8,654             1            8,654  ...........           4,327
AB reporting to FDA; AB \5\--900.4(h)................          5                1          5            10               50  ...........  ..............
AB financial records--900.4(i)(2)....................          1                1          1            16               16  ...........  ..............
Former AB new application--900.6(c)(1)...............          0.1              1          0.1          60                6  ...........  ..............
Reconsideration of accreditation following appeal--            1                1          1             2                2  ...........  ..............
 900.15(d)(3)(ii)....................................
Application for alternative standard--900.18(c)......          2                1          2             2                4  ...........  ..............
Alternative standard amendment--900.18(e)............         10                1         10             1               10  ...........  ..............
Certification agency application--900.21(b)..........          0.33             1          0.33        320              106  ...........             208
Certification agency application deficiencies--                0.1              1          0.1          30                3  ...........  ..............
 900.21(c)(2)........................................
Certification electronic data transmission--900.22(h)          5              200       1000             0.083           83       30,000  ..............
Changes to standards--900.22(i)......................          2                1          2            30               60  ...........              20
Certification agency minor deficiencies--900.24(b)...          1                1          1            30               30  ...........  ..............
Appeal of adverse action taken by FDA--900.25(a).....          0.2              1          0.2          16                3  ...........  ..............
Inspection fee exemption--Form FDA 3422..............        700                1        700             0.25           175  ...........  ..............
                                                      --------------------------------------------------------------------------------------------------
    Total............................................  ............  ............  ............  .............       11,777       40,000          82,155
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Total hours have been rounded.
\2\ One time burden.
\3\ Refers to accreditation bodies applying to accredit specific full-field digital mammography units.
\4\ Refers to the facility component of the burden for this requirement.
\5\ Refers to the AB component of the burden for this requirement.

                                                     Table 2--Estimated Annual Recordkeeping Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Total
                                                               Number of                      Average                      Total capital   operating and
          Activity/21 CFR Section              Number of      records per    Total annual    burden per     Total hours      costs (in      maintenance
                                             recordkeepers   recordkeeper      records     recordkeeping        \1\          dollars)       costs  (in
                                                                                dollars)
--------------------------------------------------------------------------------------------------------------------------------------------------------
AB transfer of facility records--                      0.1               1            0.1          0                   1  ..............  ..............
 900.3(f)(1)...............................

Consumer complaints system; AB--900.4(g)...            5                 1            5            1                   5  ..............  ..............
Documentation of interpreting physician               87                 1           87            8                 696  ..............  ..............
 initial requirements--
 900.12(a)(1)(i)(B)(2).....................
Documentation of interpreting physician            8,654                 4       34,616            1              34,616  ..............  ..............
 personnel requirements--900.12(a)(4)......
Permanent medical record--900.12(c)(4).....        8,654                 1        8,654            1               8,654          28,000  ..............
Procedures for cleaning equipment--                8,654                52      450,008            0.083          37,351  ..............  ..............
 900.12(e)(13).............................
Audit program--900.12(f)...................        8,654                 1        8,654           16             138,464  ..............  ..............
Consumer complaints system; facility--             8,654                 2       17,308            1              17,308  ..............  ..............
 900.12(h)(2)..............................
Certification agency conflict of interest--            5                 1            5            1                   5  ..............  ..............
 900.22(a).................................
Processes for suspension and revocation of             5                 1            5            1                   5  ..............  ..............
 certificates--900.22(d)...................
Processes for appeals--900.22(e)...........            5                 1            5            1                   5  ..............  ..............
Processes for additional mammography                   5                 1            5            1                   5  ..............  ..............
 review--900.22(f).........................
Processes for patient notifications--                  3                 1            3            1                   3  ..............              30
 900.22(g).................................
Evaluation of certification agency--900.23.            5                 1            5           20                 100  ..............  ..............
Appeals--900.25(b).........................            5                 1            5            1                   5  ..............  ..............
                                            ------------------------------------------------------------------------------------------------------------
    Total..................................  .............  ..............  .............  .............         237,223          28,000              30
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Total hours have been rounded.

                                               Table 3--Estimated Annual Third-Party Disclosure Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Total
                                                                              Number of                       Average                      operating and
                  Activity/21 CFR Section                      Number of   disclosures per   Total annual    burden per     Total hours     maintenance
                                                              respondents     respondent     disclosures     disclosure         \2\         costs  (in
                                                                                dollars)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Notification of facilities that AB relinquishes its                  0.1                 1           0.1         200                  20              50
 accreditation--900.3(f)(2)................................
Clinical images; facility \3\--900.4(c), 900.11(b)(1) and        2,885                   1       2,885             1.44            4,154  ..............
 (2).......................................................
Clinical images; AB \4\--900.4(c)..........................          5                   1           5           416               2,080         230,773
Phantom images; facility \3\--900.4(d), 900.11(b)(1) and         2,885                   1       2,885             0.72            2,077  ..............
 (2).......................................................
Phantom images; AB \4\--900.4(d)...........................          5                   1           5           208               1,040  ..............
Annual equipment evaluation and survey; facility \3\--           8,654                   1       8,654             1               8,654           8,654
 900.4(e), 900.11(b)(1) and (2)............................
Annual equipment evaluation and survey; AB \4\--900.4(e)...          5                   1           5         1,730               8,650  ..............
Provisional mammography facility certificate extension               0                   1           0             0.5                 1  ..............
 application--900.11(b)(3).................................

Mammography facility certificate reinstatement application--       312                   1         312             5               1,560      24,000,000
 900.11(c).................................................
Lay summary of examination--900.12(c)(2)...................      8,654               5,085  44,055,590             0.083       3,652,464  ..............
Lay summary of examination; patient refusal \5\--                   87                   1          87             0.5                44  ..............
 900.12(c)(2)..............................................
Report of unresolved serious complaints--900.12(h)(4)......         20                   1          20             1                  20  ..............
Information regarding compromised quality; facility \3\--           20                   1          20           200               4,000             300
 900.12(j)(1)..............................................
Information regarding compromised quality; AB \4\--                 20                   1          20           320               6,400             600
 900.12(j)(1)..............................................
Patient notification of serious risk--900.12(j)(2).........          5                   1           5           100                 500          19,375
Reconsideration of accreditation--900.15(c)................          5                   1           5             2                  10  ..............
Notification of requirement to correct major deficiencies--          0.4                 1           0.4         200                  80              68
 900.24(a).................................................
Notification of loss of approval; major deficiencies--               0.15                1           0.15        100                  15           25.50
 900.24(a)(2)..............................................
Notification of probationary status--900.24(b)(1)..........          0.3                 1           0.3         200                  60              51
Notification of loss of approval; minor deficiencies--               0.15                1           0.15        100                  15           25.50
 900.24(b)(3)..............................................
                                                            --------------------------------------------------------------------------------------------
    Total..................................................  ............  ...............  .............  .............       3,691,842      24,259,921
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs associated with this collection of information.
\2\ Total hours have been rounded.
\3\ Refers to the facility component of the burden for this requirement.
\4\ Refers to the AB component of the burden for this requirement.
\5\ Refers to the situation where a patient specifically does not want to receive the lay summary of her exam.

    Dated: August 15, 2016.
Peter Lurie,
Associate Commissioner for Public Health Strategy and Analysis.
[FR Doc. 2016-19808 Filed 8-18-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: September 28, 2010 (Volume 75, Number 187)]
[Rules and Regulations]
[Page 59893-59897]
[DOCID:fr28se10-15]

-----------------------------------------------------------------------

Part IV

Securities and Exchange Commission

-----------------------------------------------------------------------

17 CFR Parts 211, 231, and 241

Commission Guidance on Presentation of Liquidity and Capital Resources
Disclosures in Management's Discussion and Analysis; Final Rule

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Parts 211, 231, and 241

[Release Nos. 33-9144; 34-62934; FR-83]

Commission Guidance on Presentation of Liquidity and Capital
Resources Disclosures in Management's Discussion and Analysis

AGENCY: Securities and Exchange Commission.

ACTION: Interpretation.

-----------------------------------------------------------------------

SUMMARY: We are providing interpretive guidance that is intended to
improve discussion of liquidity and capital resources in Management's
Discussion and Analysis of Financial Condition and Results of
Operations in order to facilitate understanding by investors of the
liquidity and funding risks facing the registrant.

DATES: Effective Date: September 28, 2010.

FOR FURTHER INFORMATION CONTACT: Questions about specific filings
should be directed to staff members responsible for reviewing the
documents the registrant files with the Commission. For general
questions about this release, contact Christina L. Padden, Attorney
Fellow in the Office of Rulemaking, at<PHONE_NUMBER> or Stephanie L.
Hunsaker, Associate Chief Accountant, at<PHONE_NUMBER>, in the
Division of Corporation Finance; or Wesley R. Bricker, Professional
Accounting Fellow, Office of the Chief Accountant at<PHONE_NUMBER>;
U.S. Securities and Exchange Commission, 100 F Street, NE., Washington,
DC 20549.

SUPPLEMENTARY INFORMATION:

I. Background

    Over the past several years, we have provided guidance and have
engaged in rulemaking initiatives to improve the presentation of
information about funding and liquidity risk.\1\ In a companion
release, we are proposing amendments to enhance the disclosure that
registrants present about short-term borrowings.\2\ The proposals in
that release would require a registrant to provide, in a separately
captioned subsection of Management's Discussion and Analysis of
Financial Condition and Results of Operations (``MD&A''), a
comprehensive explanation of its short-term borrowings, including both
quantitative and qualitative information. The proposed amendments to
MD&A would be applicable to annual and quarterly reports, proxy or
information statements that include financial statements, registration
statements under the Securities Exchange Act of 1934, and registration
statements under the Securities Act of 1933. We are also proposing
conforming amendments to Form 8-K so that the Form would use the
terminology contained in the proposed short-term borrowings disclosure
requirement. To further improve the discussion of liquidity and capital
resources in MD&A in order to facilitate understanding by investors of
the liquidity and funding risks facing the registrant, we are also
providing the following guidance with respect to existing MD&A
requirements.
---------------------------------------------------------------------------

    \1\ See, e.g., Commission Statement About Management's
Discussion and Analysis of Financial Condition and Results of
Operations, Release No. 33-8056 (Jan. 22, 2002) [67 FR 3746];
Disclosure in Management's Discussion and Analysis About Off Balance
Sheet Arrangements, Contractual Obligations and Contingent
Liabilities and Commitments, Release No. 33-8144 (Nov. 4, 2002) [67
FR 68054]; Disclosure in Management's Discussion and Analysis About
Off Balance Sheet Arrangements, Contractual Obligations and
Contingent Liabilities and Commitments, Release No. 33-8182 (Jan.
28, 2003) [68 FR 5982] (adopting rules for disclosure in MD&A of
off-balance sheet arrangements and aggregate contractual
obligations); and Commission Guidance Regarding Management's
Discussion and Analysis of Financial Condition and Results of
Operations, Release No. 33-8350 (Dec. 19, 2003) [68 FR 75056]
(providing interpretive guidance on disclosure in MD&A, including
liquidity and capital resources).
    \2\ See Short-Term Borrowings Disclosure, Release No. 33-9143
(the ``Proposing Release'').
---------------------------------------------------------------------------

II. Guidance on Presentation of Liquidity and Capital Resources
Disclosures in Management's Discussion and Analysis

A. Liquidity Disclosure

    As discussed in the Proposing Release, companies have expanded the
types of funding methods and cash management tools they use. We remind
registrants that Item 303(a)(1) of Regulation S-K requires them to
``identify and separately describe internal and external sources of
liquidity, and briefly discuss any material unused sources of
liquidity.'' Accordingly, as the financing activities undertaken by
registrants become more diverse and complex, it is increasingly
important that the discussion and analysis of liquidity and capital
resources provided by registrants meet the objectives of MD&A
disclosure.
    In 2003, the Commission issued interpretive guidance relating to
MD&A disclosures of liquidity and capital resources, as well as MD&A
generally.\3\ We encourage registrants to review that guidance when
preparing their MD&A, as it covers topics relating to the discussion of
cash requirements, cash management, sources and uses of cash, as well
as a registrant's debt instruments, guarantees and related covenants,
that continue to be relevant to investors.
---------------------------------------------------------------------------

    \3\ See Commission Guidance Regarding Management's Discussion
and Analysis of Financial Condition and Results of Operations,
Release No. 33-8350 (Dec. 19, 2003) [68 FR 75056] (the ``2003
Interpretive Release'').
---------------------------------------------------------------------------

    As we have stated in the past, MD&A requires companies to provide
investors with disclosure that facilitates an appreciation of the known
trends and uncertainties that have impacted historical results or are
reasonably likely to shape future periods.\4\ This disclosure should
both discuss and analyze the company's business from the perspective of
management.\5\ In the context of liquidity, Item 303(a)(1) of
Regulation S-K requires disclosure of known trends or any known
demands, commitments, events or uncertainties that will result in, or
that are reasonably likely to result in, the registrant's liquidity
increasing or decreasing in any material way.\6\ In past guidance, the
Commission has highlighted a number of issues for management to
consider when identifying trends, demands, commitments, events and
uncertainties that require disclosure in MD&A.\7\ Some additional
important trends and uncertainties relating to liquidity might include,
for example, difficulties accessing the debt markets, reliance on
commercial paper or other short-term financing arrangements, maturity
mismatches between borrowing sources and the assets funded by those
sources,

changes in terms requested by counterparties, changes in the valuation
of collateral, and counterparty risk.
---------------------------------------------------------------------------

    \4\ See Disclosure in Management's Discussion and Analysis About
Off Balance Sheet Arrangements, Contractual Obligations and
Contingent Liabilities and Commitments, Release No. 33-8182 (Jan.
28, 2003) [68 FR 5982] (the ``OBS Adopting Release''), at 5982
(``MD&A also provides a unique opportunity for management to provide
investors with an understanding of its view of the financial
performance and condition of the company, an appreciation of what
the financial statements show and do not show, as well as important
trends and risks that have shaped the past and are reasonably likely
to shape the future.'').
    \5\ ``MD&A should be a discussion and analysis of a company's
business as seen through the eyes of those who manage that business.
Management has a unique perspective on its business that only it can
present. As such, MD&A should not be a recitation of financial
statements in narrative form, or an otherwise uninformative series
of technical responses to MD&A requirements, neither of which
provides this important management perspective.'' See 2003
Interpretive Release, supra note 3, at 75056.
    \6\ ``The scope of the discussion should thus address liquidity
in the broadest sense, encompassing internal as well as external
sources, current conditions as well as future commitments and known
trends, changes in circumstances and uncertainties.'' See Commission
Statement About Management's Discussion and Analysis of Financial
Condition and Results of Operations, Release No. 33-8056 (Jan. 22,
2002) [67 FR 3746] (the ``2002 Interpretive Release''), at 3748
n.11.
    \7\ See 2002 Interpretive Release, supra note 5, at 3748.
---------------------------------------------------------------------------

    In addition, in the context of liquidity and capital resources, if
the registrant's financial statements do not adequately convey the
registrant's financing arrangements during the period, or the impact of
those arrangements on liquidity, because of a known trend, demand,
commitment, event or uncertainty, additional narrative disclosure
should be considered and may be required to enable an understanding of
the amounts depicted in the financial statements. For example,
depending on the registrant's circumstances, if borrowings during the
reporting period are materially different than the period-end amounts
recorded in the financial statements, disclosure about the intra-period
variations is required under current rules to facilitate investor
understanding of the registrant's liquidity position.
    Moreover, the Commission's staff has noted that there may be
confusion on the part of registrants about how to address disclosure of
certain repurchase agreements that are accounted for as sales, as well
as other types of short-term financings that are not otherwise fully
captured in period-end balance sheets.\8\ Again, disclosure is required
in MD&A where a known commitment, event or uncertainty will result in
(or is reasonably likely to result in) the registrant's liquidity
increasing or decreasing in a material way.\9\ The absence of specific
references in existing disclosure requirements for off-balance sheet
arrangements or contractual obligations to repurchase transactions that
are accounted for as sales, or to any other transfers of financial
assets that are accounted for as sales, does not relieve registrants
from the disclosure requirements of Item 303(a)(1).\10\ Further, as
stated in the 2002 Interpretive Release, legal opinions regarding
``true sale'' issues do not obviate the need for registrants to
consider whether disclosure is required.\11\ In evaluating whether
disclosure in MD&A may be required in connection with a repurchase
transaction, securities lending transaction, or any other transaction
involving the transfer of financial assets with an obligation to
repurchase financial assets, that has been accounted for as a sale
under applicable accounting standards, the registrant should consider
whether the transaction is reasonably likely to result in the use of a
material amount of cash or other liquid assets. Disclosure may be
required in the discussion of liquidity and capital resources,
particularly where the registrant does not otherwise include such
information in its off-balance sheet arrangements or its contractual
obligations table. A registrant may determine where in its MD&A this
information would be most informative based on the type of obligation
and potential exposure involved, with an emphasis on providing
disclosure that is clear and not misleading.
---------------------------------------------------------------------------

    \8\ In its 2005 OBS Report, the Commission's staff identified
transfers of assets with continuing involvement as one of the
principal areas in need of improvement in disclosure of off-balance
sheet arrangements. See Staff of the U.S. Securities and Exchange
Commission, Report and Recommendations Pursuant to Section 401(c) of
the Sarbanes-Oxley Act of 2002 On Arrangements with Off-Balance
Sheet Implications, Special Purpose Entities and Transparency of
Filings by Issuers (June 2005), available at http://www.sec.gov/
news/studies/soxoffbalancerpt.pdf. See also, the Division of
Corporation Finance, Sample Letter Sent to Public Companies Asking
for Information Related to Repurchase Agreements, Securities Lending
Transactions, or Other Transactions Involving the Transfer of
Financial Assets (Mar. 2010), available at http://www.sec.gov/
divisions/corpfin/guidance/cforepurchase0310.htm., and the Division
of Corporation Finance, Sample Letter Sent to Public Companies That
Have Identified Investments in Structured Investment Vehicles,
Conduits or Collateralized Debt Obligations (Off-balance Sheet
Entities) (Dec. 2007) available at http://www.sec.gov/divisions/
corpfin/guidance/cfoffbalanceltr1207.htm.
    \9\ See Item 303(a)(1) [17 CFR 229.303(a)(1)].
    \10\ We also note that, in 1986, the Commission adopted changes
to Rule 4-08 of Regulation S-X to require financial statement
footnote disclosure of the nature and extent of a registrant's
repurchase and reverse repurchase transactions and the degree of
risk involved. See Disclosure Amendments to Regulation S-X Regarding
Repurchase and Reverse Repurchase Agreements, Release No. 33-6621
(Jan. 22, 1986) [51 FR 3765]. These requirements focus on disclosure
of risk of loss due to counter-party default. See Rule 4-08(m) of
Regulation S-X [17 CFR 210.4-08m]. However, the adopting release
indicates that the requirements do not affect obligations under MD&A
requirements to discuss ``any material impact on liquidity or
operations and risk resulting from involvement with repurchase and
reverse repurchase agreements.''
    \11\ See 2002 Interpretive Release, supra note 5, at 3749.
---------------------------------------------------------------------------

    To provide context for the exposures identified in MD&A, companies
should also consider describing cash management and risk management
policies that are relevant to an assessment of their financial
condition. Banks, in particular, should consider discussing their
policies and practices in meeting applicable banking agency guidance on
funding and liquidity risk management, or any policies and practices
that differ from applicable agency guidance. In addition, a company
that maintains or has access to a portfolio of cash and other
investments that is a material source of liquidity should consider
providing information about the nature and composition of that
portfolio, including a description of the assets held and any related
market risk, settlement risk or other risk exposure. This could include
information about the nature of any limits or restrictions and their
effect on the company's ability to use or to access those assets to
fund its business operations.
    Transparent financial reporting that conveys a complete and
understandable picture of a company's financial position reduces
uncertainty in our markets. Surprises to investors can be reduced or
avoided when a company provides clear and understandable information
about known trends, events, demands, commitments and uncertainties,
particularly where they are reasonably likely to have a current or
future material impact on that company. The economic environment is not
static. Circumstances and risks change and, as a result, disclosure
about those circumstances and risks must also evolve. As we stated in
the 2003 Interpretive Release, if prior disclosure ``does not
adequately foreshadow subsequent events, or if new information that
impacts known trends and uncertainties becomes apparent * * *
additional disclosure should be considered and may be required.'' \12\
This principle is equally applicable in the context of liquidity and
capital resources disclosure.
---------------------------------------------------------------------------

    \12\ See 2003 Interpretive Release, supra note 3, at 75061, and
Management's Discussion and Analysis of Financial Condition and
Results of Operations; Certain Investment Company Disclosures,
Release No. 33-6835 (May 18, 1989) [54 FR 22427] (the ``1989
Interpretive Release''). The 1989 Interpretive Release clarifies
that material changes to items disclosed in MD&A in annual reports
should be discussed in the quarter in which they occur. The 2003
Interpretive Release states that ``there may also be circumstances
where an item may not be material in the context of a discussion of
annual results of operations but is material in the context of
interim results.''
---------------------------------------------------------------------------

B. Leverage Ratio Disclosures

    Where a registrant includes capital or leverage ratio disclosure in
its filings with the Commission, and there are no regulatory
requirements prescribing the calculation of that ratio, or where a
registrant includes capital or leverage ratios that are calculated
using a methodology that is modified from its prescribed form, we
remind registrants of our long-standing approach to disclosure of
financial measures and non-financial measures in MD&A. First, the
registrant should determine whether the measure is a financial measure.
If the measure is not a financial measure, registrants should refer to
the guidance we provided in 2003 for disclosures relating to non-
financial measures, such

as industry metrics or value metrics.\13\ If the measure is a financial
measure, the registrant should next determine whether the measure falls
within the scope of our requirements for non-GAAP financial measures,
and if it is, the registrant would need to follow our rules and
guidance governing the inclusion of non-GAAP financial measures in
filings with the Commission.\14\
---------------------------------------------------------------------------

    \13\ See 2003 Interpretive Release, supra note 3, at 75060.
    \14\ See Conditions for Use of Non-GAAP Financial Measures,
Release No. 33-8176 (Jan. 22, 2003) [68 FR 4820] and Item 10(e) of
Regulation S-K [17 CFR 229.10(e)(5)]. We note that existing rules
and guidance governing the inclusion of non-GAAP financial measures
in filings with the Commission do not apply to financial measures
that are ``required to be disclosed by GAAP, Commission rules, or a
system of regulation of a government or governmental authority or
self-regulatory organization that is applicable to the registrant.
---------------------------------------------------------------------------

    In any event, any ratio or measure included in a filing should be
accompanied by a clear explanation of the calculation methodology. The
explanation would need to clearly articulate the treatment of any
inputs that are unusual, infrequent or non-recurring, or that are
otherwise adjusted so that the ratio is calculated differently from
directly comparable measures. Similar to our guidance for the
disclosure of non-financial measures, if the financial measure
presented differs from other measures commonly used in the registrant's
industry, the registrant would need to consider whether a discussion of
those differences or presentation of those measures would be necessary
to make the disclosures not misleading. Finally, a registrant would
need to consider its reasons for presenting the particular financial
measure, and should include disclosure clearly stating why the measure
is useful to understanding its financial condition. Where the ratio is
being presented in connection with disclosure on debt instruments and
related covenants, registrants should also consult our past guidance on
disclosure of debt instruments, guarantees and related covenants.\15\
---------------------------------------------------------------------------

    \15\ See 2003 Interpretive Release, supra note 3, at 75064.
---------------------------------------------------------------------------

C. Contractual Obligations Table Disclosures

    As an aid to understanding other liquidity and capital resources
disclosures in MD&A, the contractual obligations tabular disclosure
should be prepared with the goal of presenting a meaningful snapshot of
cash requirements arising from contractual payment obligations. The
Commission's staff has observed that divergent practices have developed
in connection with the contractual obligations table disclosure, with
registrants drawing different conclusions about the information to be
included and the manner of presentation. The requirement itself permits
flexibility so that the presentation can reflect company-specific
information in a way that is suitable to a registrant's business.
Accordingly, registrants are encouraged to develop a presentation
method that is clear, understandable and appropriately reflects the
categories of obligations that are meaningful in light of its capital
structure and business. Registrants should highlight any changes in
presentation that are made, so that investors are able to use the
information to make comparisons from period to period.
    Since the adoption of Item 303(a)(5), registrants and industry
groups have raised questions to our staff about how to treat a number
of items under the contractual obligations requirement, including:
interest payments, repurchase agreements, tax liabilities, synthetic
leases, and obligations that arise under off-balance sheet
arrangements. In addition, a variety of questions has been raised with
our staff in the context of purchase obligations. Because the questions
that arise tend to be fact-specific and closely related to a
registrant's particular business and circumstances, we have not issued
general guidance as to how to treat these items or other questions
regarding the presentation of the contractual obligations table. The
purpose of the contractual obligations table is to provide aggregated
information about contractual obligations and contingent liabilities
and commitments in a single location so as to improve transparency of a
registrant's short-term and long-term liquidity and capital resources
needs and to provide context for investors to assess the relative role
of off-balance sheet arrangements; \16\ registrants should prepare the
disclosure consistent with that objective. Uncertainties about what to
include or how to allocate amounts over the periods required in the
table should be resolved consistent with the purpose of the disclosure.
To that end, footnotes should be used to provide information necessary
for an understanding of the timing and amount of the specified
contractual obligations, as indicated in the instructions contained in
Item 303(a)(5)(i), or, where necessary to promote understanding of the
tabular data, additional narrative discussion outside of the table
should be considered. Registrants should determine how best to present
the information that is relevant to their own business in a manner that
is clear, consistent with the purpose of the disclosure and not
misleading, and should provide additional disclosure where necessary to
explain what the tabular data includes and does not include.\17\
---------------------------------------------------------------------------

    \16\ See OBS Adopting Release, supra note 4, at 5990.
    \17\ As an example, if useful to a clear understanding of the
information presented, a registrant might consider separating
amounts in the table into those that are reflected on the balance
sheet and those arising from off-balance sheet arrangements,
particularly where such a distinction helps to tie the information
to financial statement disclosure and other MD&A discussion.
---------------------------------------------------------------------------

III. Codification Update

    The ``Codification of Financial Reporting Policies'' announced in
Financial Reporting Release 1 (April 15, 1982) [47 FR 21028] is updated
by adding new Section 501.03.a.i, captioned ``Additional Guidance on
Presentation of Liquidity and Capital Resources Disclosures'' to the
Financial Reporting Codification and under that caption including the
text in Section II of this release.
    The Codification is a separate publication of the Commission. It
will not be published in the Federal Register/Code of Federal
Regulations.

List of Subjects in 17 CFR Parts 211, 231 and 241

    Securities.

Amendments to the Code of Federal Regulations

0
For the reasons set forth above, under the authority at Sections 6, 7,
10 and 9(a) of the Securities Act and Sections 12, 13, 14, 15(d) and
23(a) of the Exchange Act, the Commission is amending title 17, chapter
II of the Code of Federal Regulations as set forth below:

PART 211--INTERPRETATIONS RELATING TO FINANCIAL REPORTING MATTERS

0
1. Part 211, subpart A, is amended by adding Release No. FR-83 to the
list of interpretive releases as follow:

--------------------------------------------------------------------------------------------------------------------------------------------------------
                 Subject                     Release No.                         Date                                 Fed. Reg. vol. and page
--------------------------------------------------------------------------------------------------------------------------------------------------------

                                                                      * * * * * * *
Commission Guidance on Presentation of               FR-83  September 17, 2010...........................  75 FR [FR PAGE PAGE NUMBER].
 Liquidity and Capital Resources
 Disclosures in Management's Discussion
 and Analysis.
--------------------------------------------------------------------------------------------------------------------------------------------------------

PART 231--INTERPRETATIVE RELEASES RELATING TO THE SECURITIES ACT OF
1933 AND GENERAL RULES AND REGULATIONS THEREUNDER

0
2. Part 231 is amended by adding Release No. 33-9144 to the list of
interpretive releases as follow:

--------------------------------------------------------------------------------------------------------------------------------------------------------
                 Subject                     Release No.                         Date                                 Fed. Reg. vol. and page
--------------------------------------------------------------------------------------------------------------------------------------------------------

                                                                      * * * * * * *
Commission Guidance on Presentation of             33-9144  September 17, 2010...........................  75 FR [FR PAGE PAGE NUMBER].
 Liquidity and Capital Resources
 Disclosures in Management's Discussion
 and Analysis.
--------------------------------------------------------------------------------------------------------------------------------------------------------

PART 241--INTERPRETATIVE RELEASES RELATING TO THE SECURITIES
EXCHANGE ACT OF 1934 AND GENERAL RULES AND REGULATIONS THEREUNDER

0
3. Part 241 is amended by adding Release No. 34-62934 to the list of
interpretive releases as follow:

--------------------------------------------------------------------------------------------------------------------------------------------------------
                 Subject                     Release No.                         Date                                 Fed. Reg. vol. and page
--------------------------------------------------------------------------------------------------------------------------------------------------------

                                                                      * * * * * * *
Commission Guidance on Presentation of            34-62934  September 17, 2010...........................  75 FR [FR PAGE PAGE NUMBER].
 Liquidity and Capital Resources
 Disclosures in Management's Discussion
 and Analysis.
--------------------------------------------------------------------------------------------------------------------------------------------------------

    Dated: September 17, 2010.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2010-23744 Filed 9-27-10; 8:45 am]
BILLING CODE 8010-01-P


[Federal Register Volume 77, Number 196 (Wednesday, October 10, 2012)]
[Notices]
[Pages 61653-61654]
[FR Doc No: 2012-24679]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Notice of Intent To Rule on Request To Release Airport Property
at the McKellar-Sipes Regional Airport, Jackson, TN

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Request for public comment.

-----------------------------------------------------------------------

SUMMARY: The Federal Aviation Administration is requesting public
comment on the release of land at the McKellar-Sipes Regional Airport,
in the city of Jackson, TN. This property, approximately 4.0 acres,
will change to a non-aeronautical use. This action is taken under the
provisions of 49 U.S.C. Section 47107(h)(2) requiring public notice
before a waiver of property designated to be used for an aeronautical
purpose is granted.

DATES: Comments must be received on or before November 9, 2012.

ADDRESSES: Documents are available for review at the McKellar-Sipes
Regional Airport, 308 Grady Montgomery Drive, Jackson, TN. 38301 and
the FAA Airports District Office, 2862 Business Park Drive, Building G,
Memphis, TN 38118. Written comments on the Sponsor's request must be
delivered or mailed to: Mr. Phillip J. Braden, Manager, Memphis
Airports District Office, 2862 Business Park Drive, Building G,
Memphis, TN 38118.
    In addition, a copy of any comments submitted to the FAA must be
mailed or delivered to Mr. Steve Smith, Executive Director, Jackson--
Madison County Airport Authority, 308 Grady Montgomery Drive, Jackson,
TN. 38301.

FOR FURTHER INFORMATION CONTACT: Mr. Michael Thompson, Program Manager,
Federal Aviation Administration, Memphis Airports District Office, 2862
Business Park Drive, Building G, Memphis, TN 38118. The application may
be reviewed in person at this same location, by appointment.

SUPPLEMENTARY INFORMATION: The FAA proposes to rule and invites public
comment on the request to release property at the McKellar-Sipes
Regional Airport, Jackson, TN Under the provisions of 49 U.S.C.
47107(h)(2).
    On October 1, 2012, the FAA determined that the request to release
property at McKellar-Sipes Regional Airport meets the procedural
requirements of the Federal Aviation Administration. The FAA may
approve the request, in whole or in part, no later than November 9,
2012.
    The following is a brief overview of the request:
    The McKellar-Sipes Regional Airport is proposing the release of
approximately 4.0 acres of airport property so the property can be used
to accommodate the construction of a new Madison County Fire Department
vehicle maintenance facility. This property is located on Technology
Center Drive adjacent to the Tennessee Technology Center outside of the
airport perimeter fence.
    Any person may inspect, by appointment, the request in person at

the FAA office listed above under FOR FURTHER INFORMATION CONTACT.
    In addition, any person may, upon appointment and request, inspect
the request, notice and other documents germane to the request in
person at the Tennessee Department of Transportation, Division of
Aeronautics.

    Issued in Memphis, TN on October 1, 2012.
Phillip J. Braden,
Manager, Memphis Airports District Office, Southern Region.
[FR Doc. 2012-24679 Filed 10-9-12; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 110 (Friday, June 7, 2013)]
[Notices]
[Pages 34368-34369]
[FR Doc No: 2013-13592]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 2

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-2238-005; ER10-2239-005; ER10-2237-004; ER10-
1821-006; ER11-4475-006; ER12-896-001.
    Applicants: Indigo Generation LLC, Larkspur Energy LLC, Wildflower
Energy LP, Goshen Phase II LLC, Rockland Wind Farm LLC, Mariposa
Energy, LLC.
    Description: Notice of Non-Material Change in Status of the DGC
Companies, et al.
    Filed Date: 5/28/13.
    Accession Number: 20130528-5171.
    Comments Due: 5 p.m. ET 6/18/13.

    Docket Numbers: ER10-3297-002.
    Applicants: Powerex Corporation.
    Description: Powerex Corporation submits Notice of Non-Material
Change in Status.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5129.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER12-1932-004; ER12-1933-005; ER12-1934-004.
    Applicants: Franklin County Wind, LLC, Interstate Power and Light

Company, Wisconsin Power and Light Company.
    Description: Change in Status Report of the Alliant Companies, et
al.
    Filed Date: 5/28/13.
    Accession Number: 20130528-5115.
    Comments Due: 5 p.m. ET 6/18/13.

    Docket Numbers: ER13-1422-002.
    Applicants: Ebensburg Power Company.
    Description: Inquiry Response to be effective 5/12/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5044.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1564-000.
    Applicants: NV Energy, Inc.
    Description: Service Agreement No. 13-00014 NITS Retail Access TSA
CRC--City of Las Vegas to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5008.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1565-000.
    Applicants: NV Energy, Inc.
    Description: Service Agreement No. 13-00017 NITS Retail Access TSA
CRC--City of Henderson to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5010.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1566-000.
    Applicants: NV Energy, Inc.
    Description: Service Agreement No. 13-00020 NITS Retail Access TSA
CRC--SNWA to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5011.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1567-000.
    Applicants: NV Energy, Inc.
    Description: Service Agreement No. 13-00019 NITS Retail Access TSA
CRC--CCWRD to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5013.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1568-000.
    Applicants: Southwest Power Pool, Inc.
    Description: 1066R5 Northeast Texas Electric Cooperative NITSA and
NOA to be effective 5/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5041.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1569-000.
    Applicants: Southwest Power Pool, Inc.
    Description: 1065R2 Tex-La Electric Cooperative of Texas NITSA and
NOA to be effective 5/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5079.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1570-000.
    Applicants: East Kentucky Power Cooperative, Inc.
    Description: Cancellation of Tariff to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5101.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1571-000.
    Applicants: Southwest Power Pool, Inc.
    Description: 2551 Kansas Municipal Energy Agency NITSA and NOA to
be effective 5/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5114.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1572-000.
    Applicants: Southwest Power Pool, Inc.
    Description: 1067R2 East Texas Electric Cooperative NITSA and NOA
to be effective 5/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5115.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1573-000.
    Applicants: Imperial Valley Solar, LLC.
    Description: Certificate of Concurrence for Co-Tenancy and Shared
Use Agreement to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5116.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1574-000.
    Applicants: Imperial Valley Solar 1, LLC.
    Description: Certificate of Concurrence for Co-Tenancy and Shared
Use Agreement to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5117.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1575-000.
    Applicants: AEP Texas North Company.
    Description: TNC-White Camp Solar Interconnection Agreement to be
effective 4/30/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5120.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1576-000.
    Applicants: NV Energy, Inc.
    Description: Service Agreement No. 13-00021 NITS--Retail Access TSA
CRC--LVVWD to be effective 6/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5133.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1577-000.
    Applicants: AEP Texas North Company.
    Description: TNC-SWTEC Amd 2 to Restated & Amended IA to
be effective 5/1/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5140.
    Comments Due: 5 p.m. ET 6/19/13.

    Docket Numbers: ER13-1578-000.
    Applicants: Magnolia Energy LP.
    Description: Application for Market-Based Rate Authorization to be
effective 5/30/2013.
    Filed Date: 5/29/13.
    Accession Number: 20130529-5143.
    Comments Due: 5 p.m. ET 6/19/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: May 29, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-13592 Filed 6-6-13; 8:45 am]
BILLING CODE 6717-01-P